Literature DB >> 12389035

Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice.

Jiri G Safar1, Michael Scott, Jeff Monaghan, Camille Deering, Svetlana Didorenko, Julie Vergara, Haydn Ball, Giuseppe Legname, Estelle Leclerc, Laura Solforosi, Hana Serban, Darlene Groth, Dennis R Burton, Stanley B Prusiner, R Anthony Williamson.   

Abstract

There is increasing concern over the extent to which bovine spongiform encephalopathy (BSE) prions have been transmitted to humans, as a result of the rising number of variant Creutzfeldt-Jakob disease (vCJD) cases. Toward preventing new transmissions, diagnostic tests for prions in livestock have been developed using the conformation-dependent immunoassay (CDI), which simultaneously measures specific antibody binding to denatured and native forms of the prion protein (PrP). We employed high-affinity recombinant antibody fragments (recFab) reacting with residues 95-105 of bovine (Bo) PrP for detection and another recFab that recognizes residues 132-156 for capture in the CDI. We report that the CDI is capable of measuring the disease-causing PrP isoform (PrP(Sc)) in bovine brainstems with a sensitivity similar to that of end-point titrations in transgenic (Tg) mice expressing BoPrP. Prion titers were approximately 10(7) ID(50) units per gram of bovine brainstem when measured in Tg(BoPrP) mice, a figure approximately 10 times greater than that determined by bioassay in cattle and approximately 10,000x greater than in wild-type mice. We also report substantial differences in BoPrP(Sc) levels in different areas of the obex region, where neuropathology has been consistently observed in cattle with BSE. The CDI was able to discriminate between PrP(Sc) from BSE-infected cattle and Tg(BoPrP) mice as well as from chronic wasting disease (CWD)-infected deer and elk. Our findings argue that applying the CDI to livestock should considerably reduce human exposure to animal prions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12389035     DOI: 10.1038/nbt748

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  89 in total

1.  Conformation-dependent high-affinity monoclonal antibodies to prion proteins.

Authors:  Larry H Stanker; Ana V Serban; Elisa Cleveland; Robert Hnasko; Azucena Lemus; Jiri Safar; Stephen J DeArmond; Stanley B Prusiner
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

2.  Simulations of oligomeric intermediates in prion diseases.

Authors:  David L Mobley; Daniel L Cox; Rajiv R P Singh; Rahul V Kulkarni; Alexander Slepoy
Journal:  Biophys J       Date:  2003-10       Impact factor: 4.033

3.  Sensitivity of protein misfolding cyclic amplification versus immunohistochemistry in ante-mortem detection of chronic wasting disease.

Authors:  Nicholas J Haley; Candace K Mathiason; Scott Carver; Glenn C Telling; Mark D Zabel; Edward A Hoover
Journal:  J Gen Virol       Date:  2012-01-25       Impact factor: 3.891

4.  Transmission of elk and deer prions to transgenic mice.

Authors:  Gültekin Tamgüney; Kurt Giles; Essia Bouzamondo-Bernstein; Patrick J Bosque; Michael W Miller; Jiri Safar; Stephen J DeArmond; Stanley B Prusiner
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

5.  Evidence for degradation of abnormal prion protein in tissues from sheep with scrapie during composting.

Authors:  Hongsheng Huang; J Lloyd Spencer; Andrei Soutyrine; Jeiwen Guan; Jasmine Rendulich; Aru Balachandran
Journal:  Can J Vet Res       Date:  2007-01       Impact factor: 1.310

6.  Use of thermolysin in the diagnosis of prion diseases.

Authors:  Jonathan P Owen; Ben C Maddison; Garry C Whitelam; Kevin C Gough
Journal:  Mol Biotechnol       Date:  2007-02       Impact factor: 2.695

7.  Diagnosis of human prion disease.

Authors:  Jiri G Safar; Michael D Geschwind; Camille Deering; Svetlana Didorenko; Mamta Sattavat; Henry Sanchez; Ana Serban; Martin Vey; Henry Baron; Kurt Giles; Bruce L Miller; Stephen J Dearmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-01       Impact factor: 11.205

8.  Prion disease tempo determined by host-dependent substrate reduction.

Authors:  Charles E Mays; Chae Kim; Tracy Haldiman; Jacques van der Merwe; Agnes Lau; Jing Yang; Jennifer Grams; Michele A Di Bari; Romolo Nonno; Glenn C Telling; Qingzhong Kong; Jan Langeveld; Debbie McKenzie; David Westaway; Jiri G Safar
Journal:  J Clin Invest       Date:  2014-01-16       Impact factor: 14.808

9.  Progress and problems in the biology, diagnostics, and therapeutics of prion diseases.

Authors:  Adriano Aguzzi; Mathias Heikenwalder; Gino Miele
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

10.  Engineering a murine cell line for the stable propagation of hamster prions.

Authors:  Matthew E C Bourkas; Hamza Arshad; Zaid A M Al-Azzawi; Ondrej Halgas; Ronald A Shikiya; Mohadeseh Mehrabian; Gerold Schmitt-Ulms; Jason C Bartz; Joel C Watts
Journal:  J Biol Chem       Date:  2019-01-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.